Page last updated: 2024-10-29

iohexol and Cerebrovascular Moyamoya Disease

iohexol has been researched along with Cerebrovascular Moyamoya Disease in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohno, T1
Kudo, K1
Zaharchuk, G1
Fujima, N1
Shirato, H1
Yang, CY1
Chen, YF1
Lee, CW1
Huang, A1
Shen, Y1
Wei, C1
Liu, HM1

Other Studies

2 other studies available for iohexol and Cerebrovascular Moyamoya Disease

ArticleYear
Evaluation of diagnostic accuracy in CT perfusion analysis in moyamoya disease.
    Japanese journal of radiology, 2016, Volume: 34, Issue:1

    Topics: Adult; Aged; Blood Flow Velocity; Carotid Arteries; Cerebral Arteries; Cerebrovascular Circulation;

2016
Multiphase CT angiography versus single-phase CT angiography: comparison of image quality and radiation dose.
    AJNR. American journal of neuroradiology, 2008, Volume: 29, Issue:7

    Topics: Adult; Aged; Carotid Stenosis; Cerebral Angiography; Cerebral Arterial Diseases; Cerebral Infarction

2008